Metal-protein attenuating compounds and Alzheimer's disease (Q35964717)

11 August 2017

1 reference

title

Metal-protein attenuating compounds and Alzheimer's disease (English)

1 reference

11 August 2017

0 references

Ashley I Bush

2

0 references

Colin L. Masters

series ordinal

3

object named as

Colin L Masters

1 reference

11 August 2017

1

Craig W Ritchie

1 reference

PubMed ID

15566316

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Expert Opinion on Investigational Drugs

11 August 2017

1 reference

11 August 2017

13

1 reference

11 August 2017

12

1 reference

11 August 2017

1585-1592

1 reference

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

11 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Characterization of beta-amyloid peptide from human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Role of mitochondrial dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Immunotherapeutic Approaches to Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Distribution of presenilin 1 and 2 and their relation to Notch receptors and ligands in human embryonic/foetal central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Synaptically released zinc: physiological functions and pathological effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

The metallobiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Treatment of Alzheimer's disease with clioquinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Clioquinol's return: cautions from Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Neurological syndrome associated with clioquinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Alpha-synuclein and the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1585

10.1517/13543784.13.12.1585

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15566316